PREVYMIS 20 mg/mL
LETERMOVIR · INJECTION, SOLUTION · Merck Sharp & Dohme LLC
Prevymis (letermovir) is an injectable medication used to prevent cytomegalovirus infection in certain high-risk patients who have received a stem cell transplant. It works by inhibiting a viral enzyme needed for cytomegalovirus replication.
Key Facts
- Brand Name
- PREVYMIS
- Generic Name
- LETERMOVIR
- NDC Code (Product)
0006-5004- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA209940
- Drug Class
- Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]
- Marketing Start
- 11/08/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is PREVYMIS used for?
Prevymis (letermovir) is an injectable medication used to prevent cytomegalovirus infection in certain high-risk patients who have received a stem cell transplant. It works by inhibiting a viral enzyme needed for cytomegalovirus replication.
Is PREVYMIS a controlled substance?
PREVYMIS is not classified as a controlled substance by the DEA.
What is the generic name for PREVYMIS?
The generic name for PREVYMIS is LETERMOVIR. There are no other listed brand versions of LETERMOVIR.
What is the NDC code for PREVYMIS 20 mg/mL?
The NDC (National Drug Code) for PREVYMIS 20 mg/mL is 0006-5004, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)